LIXT stock

Lixte Biotechnology Holdings Inc (LIXT) financials · $121.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Lixte Biotechnology Holdings Inc (LIXT) $121.0M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$5.11M-$3.57M
Net Income-$6.08M-$3.59M
EPS (Diluted)-$1.26-$1.59
Cached annual balance sheet
LineFY2025FY2024
Total Assets$12.7M$1.15M
Current Assets$5.18M$1.15M
Cash & Equivalents$5.11M$1.04M
PP&E$6.58MN/A
Total Liabilities$1.77M$318.3K
Current Liabilities$1.33M$318.3K
Shareholders' Equity$9.66M$827.2K
Retained Earnings-$58.1M-$52.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$3.07M-$3.16M
Investing Cash Flow-$3.17MN/A
Financing Cash Flow$10.3MN/A
Net Change in CashN/A-$3.16M
These statements as JSON? API free 100/day

FAQ

What is LIXT P/E and revenue?

Lixte Biotechnology Holdings Inc (LIXT) $121.0M cap.

What is LIXT revenue?

LIXT income-statement cache has no revenue figure yet.

Is LIXT profitable?

Lixte Biotechnology Holdings Inc last cached net income is -$6.08M (FY2025).

What are LIXT total assets?

Lixte Biotechnology Holdings Inc last cached total assets are $12.7M (FY2025).

What is LIXT free cash flow?

No cached cash-flow row for LIXT yet.

Not investment advice. Cached statements, not a live tape.